Hypertrophic scars and keloids - Etiology and management

被引:211
作者
Alster, TS [1 ]
Tanzi, EL [1 ]
机构
[1] Washington Inst Dermatol Laser Surg, Washington, DC 20037 USA
关键词
D O I
10.2165/00128071-200304040-00003
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Keloid and hypertrophic scars have affected patients and frustrated physicians for centuries. Keloid and hypertrophic scars result from excessive collagen deposition, the cause of which remains elusive. Clinically, these scars can be disfiguring functionally, aesthetically, or both. A thorough understanding of the pathophysiology and clinical nature of the scar can help define the most appropriate treatment strategy. Although many articles have been published on the management of hypertrophic and keloid scars, there is no universally accepted treatment protocol. Prevention of keloid and hypertrophic scars remains the best strategy; therefore, those patients with a predisposition to develop excessive scar formation should avoid nonessential surgery. Once a scar is present, there are many treatments from which to choose. Hypertrophic scars and keloids have been shown to respond to radiation, pressure therapy, cryotherapy, intralesional injections of corticosteroid, interferon and fluorouracil, topical silicone or other dressings, and pulsed-dye laser treatment. Simple surgical excision is usually followed by recurrence unless adjunct therapies are employed. Biologic agents that are directed towards the aberrant collagen proliferation that characterizes keloid and hypertrophic scars might be an important addition to the current armamentarium of modalities in the near future.
引用
收藏
页码:235 / 243
页数:9
相关论文
共 124 条
[111]   STERNAL KELOIDS - SUCCESSFUL TREATMENT EMPLOYING SURGERY AND ADJUNCTIVE RADIATION [J].
SHIP, AG ;
WEISS, PR ;
MINCER, FR ;
WOLKSTEIN, W .
ANNALS OF PLASTIC SURGERY, 1993, 31 (06) :481-487
[112]   TGF-β2 activates proliferative scar fibroblasts [J].
Smith, P ;
Mosiello, G ;
Deluca, L ;
Ko, F ;
Maggi, S ;
Robson, MC .
JOURNAL OF SURGICAL RESEARCH, 1999, 82 (02) :319-323
[113]  
Stegman SJ, 1990, COSMETIC DERMATOLOGI, P201
[114]  
STERN JC, 1989, ARCH OTOLARYNGOL, V115, P1107
[115]  
STUCKER FJ, 1992, ARCH OTOLARYNGOL, V118, P63
[116]   The effects of a single dose of 5-fluorouracil on keloid scars: A clinical trial of timed wound irrigation after extralesional excision [J].
Uppal, RS ;
Khan, U ;
Kakar, S ;
Talas, G ;
Chapman, P ;
McGrouther, AD .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2001, 108 (05) :1218-1224
[117]   Keloids and hypertrophic scars: Review and treatment strategies [J].
Urioste, SS ;
Arndt, KA ;
Dover, JS .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 1999, 18 (02) :159-171
[118]   Exogenous transforming growth factor β2 modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats [J].
Wang, X ;
Smith, P ;
Pu, LLQ ;
Kim, YJ ;
Ko, F ;
Robson, MC .
JOURNAL OF SURGICAL RESEARCH, 1999, 87 (02) :194-200
[119]   INTRALESIONAL INTERFERON-ALPHA-2B HAS NO EFFECT IN THE TREATMENT OF KELOIDS [J].
WONG, TW ;
CHIU, HC ;
YIP, KM .
BRITISH JOURNAL OF DERMATOLOGY, 1994, 130 (05) :683-685
[120]   Elevated interleukin-6 expression in keloid fibroblasts [J].
Xue, H ;
McCauley, RL ;
Zhang, WR .
JOURNAL OF SURGICAL RESEARCH, 2000, 89 (01) :74-77